Researchers portal

Portal del personal investigador

Searching. Please wait…

Portal del Investigador > en > Publications > publication-detail

Detalle_Publicacion

Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic

Other publications of the same journal or congress with authors from the University of Cantabria

Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting - Article
Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: multicenter study in 384 spanish patients - Article
Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study - Article
COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy versus apremilast in North Spain - Article

Fuente: Dermatologic Therapy. 2020;33:e14464.

Publisher: Wiley

Year of publication: 2020

Publication type: Article

DOI: 10.1111/dth.14464

ISSN: 1529-8019,1396-0296

Publication Url: https://doi.org/10.1111/dth.14464

Read publication

Authorship

SUSANA ARMESTO ALONSO

MARIA CARMEN GONZALEZ VELA

JULIA SÁNCHEZ

AITZIBER ILLARO

JESÚS MAYORGA

ANA E. LÓPEZ SUNDH

CRISTINA NAHARRO FERNÁNDEZ

NATALIA PALMOU

CRISTINA GÓMEZ-FERNÁNDEZ

MARCOS ANTONIO GONZALEZ LOPEZ

MIGUEL ANGEL GONZALEZ-GAY MANTECON

Download reference

Bib Ris